Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 2
2008 7
2009 6
2010 13
2011 7
2012 16
2013 14
2014 14
2015 18
2016 13
2017 9
2018 8
2019 10
2020 15
2021 11
2022 14
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Tafluprost on Ocular Blood Flow.
Zhang X, Zhou X, Zhao Y, Yang X, Zhou D, Chen B, Duan X. Zhang X, et al. Ophthalmol Ther. 2022 Dec;11(6):1991-2003. doi: 10.1007/s40123-022-00566-z. Epub 2022 Sep 15. Ophthalmol Ther. 2022. PMID: 36109465 Free PMC article. Review.
Increasing evidence indicates that improving ocular blood flow (OBF) can be a therapeutic direction for glaucoma therapy. Tafluprost, a prostaglandin analogue which lowers the intraocular pressure (IOP), has been shown to improve OBF in animals and humans. Several a …
Increasing evidence indicates that improving ocular blood flow (OBF) can be a therapeutic direction for glaucoma therapy. Taflupro …
Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
Hoy SM. Hoy SM. Drugs. 2015 Oct;75(15):1807-13. doi: 10.1007/s40265-015-0476-9. Drugs. 2015. PMID: 26431840 Review.
A once-daily preservative-free fixed combination ophthalmic solution containing tafluprost 0.0015 % and timolol 0.5 % (hereafter referred to as tafluprost/timolol) [Taptiqom()] has been developed to lower intraocular pressure (IOP) whilst avoiding damage to the ocul …
A once-daily preservative-free fixed combination ophthalmic solution containing tafluprost 0.0015 % and timolol 0.5 % (hereafter refe …
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.
Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K. Li T, et al. Ophthalmology. 2016 Jan;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005. Epub 2015 Oct 31. Ophthalmology. 2016. PMID: 26526633 Free PMC article. Review.
The mean reductions (95% credible intervals) in IOP in millimeters of mercury at 3 months ordered from the most to least effective drugs were as follows: bimatoprost 5.61 (4.94; 6.29), latanoprost 4.85 (4.24; 5.46), travoprost 4.83 (4.12; 5.54), levobunolol 4.51 (3.85; 5.24), …
The mean reductions (95% credible intervals) in IOP in millimeters of mercury at 3 months ordered from the most to least effective drugs wer …
Tafluprost for glaucoma.
Papadia M, Bagnis A, Scotto R, Traverso CE. Papadia M, et al. Expert Opin Pharmacother. 2011 Oct;12(15):2393-401. doi: 10.1517/14656566.2011.606810. Expert Opin Pharmacother. 2011. PMID: 21916788 Review.
INTRODUCTION: Lowering intraocular pressure (IOP) is, at present, the only therapeutic approach to the treatment of glaucoma. Good compliance is essential in every chronic therapy; therefore, the development of IOP-lowering eye drops that are well tolerated and have an eas …
INTRODUCTION: Lowering intraocular pressure (IOP) is, at present, the only therapeutic approach to the treatment of glaucoma. Good co …
Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension.
Swymer C, Neville MW. Swymer C, et al. Ann Pharmacother. 2012 Nov;46(11):1506-10. doi: 10.1345/aph.1R229. Epub 2012 Oct 23. Ann Pharmacother. 2012. PMID: 23092867 Review.
Tafluprost was the primary search term. Articles published between January 2008 and April 2012 were included in this review. ...Results from 1 trial demonstrated significant reductions in IOP when monotherapy was switched to tafluprost monotherapy. Reductions in IOP …
Tafluprost was the primary search term. Articles published between January 2008 and April 2012 were included in this review. ...Resul …
Tafluprost Ophthalmic Solution 0.0015 %: A Review in Glaucoma and Ocular Hypertension.
Keating GM. Keating GM. Clin Drug Investig. 2016 Jun;36(6):499-508. doi: 10.1007/s40261-016-0413-z. Clin Drug Investig. 2016. PMID: 27225879 Review.
The efficacy of tafluprost ophthalmic solution 0.0015 % was maintained in the longer term. Tafluprost ophthalmic solution 0.0015 % was generally well tolerated. ...
The efficacy of tafluprost ophthalmic solution 0.0015 % was maintained in the longer term. Tafluprost ophthalmic solution 0.00 …
Tafluprost: a novel prostaglandin analog for treatment of glaucoma.
Pantcheva MB, Seibold LK, Awadallah NS, Kahook MY. Pantcheva MB, et al. Adv Ther. 2011 Sep;28(9):707-15. doi: 10.1007/s12325-011-0055-8. Epub 2011 Aug 18. Adv Ther. 2011. PMID: 21858491 Review.
From these ressults, articles available in the English language and in full text were selected and systematically reviewed by the authors. RESULTS: Recent studies have shown that tafluprost is an effective IOP-lowering medication. Evidence based medicine also reveals that …
From these ressults, articles available in the English language and in full text were selected and systematically reviewed by the authors. R …
Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure.
Paul C. Paul C. Indian J Ophthalmol. 2023 Dec 1;71(12):3652-3657. doi: 10.4103/IJO.IJO_3312_22. Epub 2023 Nov 20. Indian J Ophthalmol. 2023. PMID: 37991299 Free PMC article.
OBJECTIVE: To investigate the intraocular pressure (IOP) lowering effect of topical preserved tafluprost 0.0015% in a tertiary hospital setting in India. METHODS: This is a retrospective chart review of patients with primary open-angle glaucoma (POAG) or ocular hypertensio …
OBJECTIVE: To investigate the intraocular pressure (IOP) lowering effect of topical preserved tafluprost 0.0015% in a tertiary hospit …
Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma.
Holló G, Katsanos A. Holló G, et al. Expert Opin Drug Saf. 2015 Apr;14(4):609-17. doi: 10.1517/14740338.2015.1010507. Epub 2015 Feb 2. Expert Opin Drug Saf. 2015. PMID: 25640746 Review.
INTRODUCTION: The preservative-free (PF) fixed combination (FC) of tafluprost 0.0015%/timolol 0.5% is the newest member of the prostaglandin analogue/timolol FC class. ...However, in contrast to most similar eye drops the tafluprost/timolol FC is manufactured in a P …
INTRODUCTION: The preservative-free (PF) fixed combination (FC) of tafluprost 0.0015%/timolol 0.5% is the newest member of the prosta …
169 results